• Demystifying biologics, their biosimilars and the PBS

  • May 18 2021
  • Length: 20 mins
  • Podcast

Demystifying biologics, their biosimilars and the PBS

  • Summary

  • In this episode, Professor Debra Rowett is joined by Professor Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee and Dr Paul Kubler, Consultant Rheumatologist to discuss how b/tsDMARDs are funded in Australia, the policies and mechanisms that influence the cost to government and how the introduction of biosimilars affects the pricing of biologics on the PBS. 

    Show More Show Less

What listeners say about Demystifying biologics, their biosimilars and the PBS

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.